Arkolith/Insider Trading/DICE/Form 4

Scopa James Paul

DirectorDICE Therapeutics, Inc. (DICE) · full profile →Form 4 · filed May 2, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2023Gift(G)7K—$015K
May 1, 2023Gift(G)7K—$031K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-026618) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML